All 1 tracked stories fall under one category: health-it. Of the tracked stories, 1 of 1 also mention GoodRx Holdings, Inc., the most common co-covered peer. Each story carries 3 original sources on average, compared with 4.7 for the broader beat in this window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Churchill Downs Incorporated
All 1 tracked stories fall under one category: health-it. Of the tracked stories, 1 of 1 also mention GoodRx Holdings, Inc., the most common co-covered peer. Each story carries 3 original sources on average, compared with 4.7 for the broader beat in this window. At 5, the average consequence score sits below the same-window beat average of 5.6. We currently track 1 Healthcare story that mention Churchill Downs Incorporated, all published on February 26, 2026.
Stories tracked
1
Sources per story
3
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 41 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Churchill Downs Incorporated. Shared-story counts are live from our verified record — not editorial picks.
GoodRx reported Q4 2025 sales that exceeded market expectations, yet shares fell nearly 12% as investors weighed future guidance and margin pressures. Meanwhile, Schrödinger is pivoting toward a hosted platform model, targeting 10-15% growth in annual contract value for its computational drug discovery suite.